GPT and Sepsis: Early (3–6 h) administration prevented sepsis-related mortality, whereas treatments initiated at later stages improved MAP; enhanced respiratory, hepatic, and renal functions, as evidenced by enhanced PaO2/FiO2 ratios and reduced urea and ALT levels; and attenuated metabolic acidosis, as indicated by decreased lactate levels.